Summary & Overview
HCPCS J2180: Injection, Meperidine and Promethazine HCl, up to 50 mg
HCPCS Level II code J2180 denotes the injectable combination of meperidine and promethazine hydrochloride, up to 50 mg. This code is used to identify administration of a paired opioid and antiemetic/antihistamine when billed as a drug supply line item. Nationally, accurate coding for this injectable combination affects claims processing, drug utilization reporting, and monitoring of controlled substance administration in acute care settings.
Key payers covered in this summary include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the drug combination, typical sites of service where the injection is administered, and what billing teams should expect when preparing service lines that include J2180.
The report outlines benchmarks and billing considerations commonly associated with HCPCS drug codes, summarizes payer coverage patterns when available, and highlights areas where coding clarity affects reimbursement and compliance. Data not available in the input will be noted where applicable. The focus is national policy and billing practice implications rather than state-specific rules or individualized clinical recommendations.
Billing Code Overview
HCPCS Level II code J2180 represents an injection of meperidine and promethazine hydrochloride, up to 50 mg. The service involves administration of a combination opioid (meperidine) with an antihistamine/antiemetic (promethazine) formulated for parenteral use.
Service Type: Combined injectable analgesic/antiemetic administration
Typical Site of Service: Outpatient clinical settings or facility-based outpatient departments where parenteral analgesia and antiemetic therapy are administered, including emergency departments, surgical recovery areas, and ambulatory procedure centers.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department, urgent care clinic, or outpatient surgical center with acute moderate to severe pain combined with nausea or as part of a short procedural sedation regimen. Common scenarios include an orthopedic injury (e.g., isolated limb fracture) requiring closed reduction, a painful laceration requiring repair, or severe musculoskeletal pain unresponsive to oral analgesics. The clinician documents indications, obtains informed consent, verifies allergies, and performs vital signs and focused physical exam. Meperidine and promethazine are administered via intramuscular or intravenous injection as ordered; monitoring of respiratory status, hemodynamics, and level of consciousness occurs during and after administration. Medication administration is documented in the medication administration record with dose, route, time, lot number, and supervising provider. Billing uses HCPCS Level II code J2180 for the injectable combination up to 50 mg, with appropriate modifier(s) appended based on circumstances (e.g., modifier 23 for unusual anesthesia, 59 or other distinct procedural modifiers only when applicable and supported by clinical documentation).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |